Trials / Completed
CompletedNCT05601258
Lipase Levels and Coronavirus Disease 2019
Association Between Pancreatic Lipase Levels and Coronavirus Disease 2019
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 4,000 (actual)
- Sponsor
- Uşak University · Academic / Other
- Sex
- —
- Age
- —
- Healthy volunteers
- —
Summary
Although COVID-19 disease due to Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) affects the respiratory tract, heart and coagulation system, symptoms of gastrointestinal system involvement such as abdominal pain, nausea, vomiting and diarrhea are also common. In this study, it was aimed retrospective analysis of clinical and laboratory data of patients who developed pancreatic injury and acute pancreatitis in the course of COVID 19 disease.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Age, gender, hospitalization and mortality rates will be compared | Age, gender, hospitalization and mortality rates will be compared |
Timeline
- Start date
- 2020-03-31
- Primary completion
- 2021-07-09
- Completion
- 2021-07-09
- First posted
- 2022-11-01
- Last updated
- 2022-11-01
Locations
1 site across 1 country: Turkey (Türkiye)
Source: ClinicalTrials.gov record NCT05601258. Inclusion in this directory is not an endorsement.